Insulet Corporation (BMV:PODD)

Mexico · Delayed Price · Currency is MXN

4,402.00

0.00 (0.00%)

At close: Feb 3, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
US Omnipod Revenue	1.80B	1.51B	1.25B
US Omnipod Revenue Growth	18.98%	20.65%	41.39%
International Omnipod Revenue	682.30M	523.40M	410.10M
International Omnipod Revenue Growth	30.36%	27.63%	12.97%
Total Omnipod Revenue	2.48B	2.03B	1.66B
Total Omnipod Revenue Growth	21.91%	22.37%	33.12%
Drug Delivery Revenue	44.00M	38.90M	36.00M
Drug Delivery Revenue Growth	13.11%	8.06%	-37.39%
Revenue (Other)	-100.00K	-	-
Revenue (Total)	2.52B	2.07B	1.70B
Revenue (Total) Growth	21.74%	22.07%	30.02%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
United States Revenue	1.84B	1.55B	1.29B
United States Revenue Growth	18.83%	20.29%	36.58%
International Revenue	682.30M	523.40M	410.10M
International Revenue Growth	30.36%	27.63%	12.97%
Revenue (Other)	-100.00K	-	-
Revenue (Total)	2.52B	2.07B	1.70B
Revenue (Total) Growth	21.74%	22.07%	30.02%

Updated Sep 30, 2025. Data Source: Fiscal.ai.